Background. Iron can induce lipid peroxidation in vitro and in vivo in humans and has promoted ischemic myocardial injury in experimental animals. We tested the hypothesis that high serum ferritin concentration and high dietary iron intake are associated with an excess risk of acute myocardial infarction.
population studies xygen free radicals promote the oxidation of lipids, which has been postulated to be involved in the development of atherosclerosis.' This is supported by the observed association between the titer of autoantibodies against oxidatively modified low density lipoprotein (LDL) and the progression of carotid atherosclerosis in men.2 Free iron catalyzes free radical production, which generates a range of potent oxidants that can induce oxidation of lipids.3-6 Thus, free iron might increase the risk of coronary heart disease (CHD) by promoting the oxidation of lipids and possibly of catecholamines. Free radical formation and lipid peroxidation can be prevented by the iron-chelating agent desferrioxamine.4-6 Iron chelators have also prevented or limited experimental myocardial ischemia or improved recovery after reperfusion injury in isolated rat hearts and other animal models. [3] [4] [5] [6] [7] [8] We have observed an association between high serum concentrations of copper, another potential promotor of lipid oxidation, and accelerated atherosclerosis and excess risk of acute myocardial infarction (AMI).9,10 We have also found accelerated atherogenesis and an increased risk of coronary and cardiovascular death in men with a low status of selenium, a cofactor of the free radical-scavenging glutathione peroxidase enzymes.9"' It has been hypothesized that iron overload is a major See p 1036 cause of the higher occurrence of CHD in men than in women.7 '12 There are, however, no previous reports concerning the relation of iron status to the risk of CHD in humans. We tested the hypothesis, formulated on the basis of chemical plausibility, that excess body iron, as estimated by serum ferritin concentration, is associated with an increased risk of AMI in middle-aged men. We also studied the association of dietary iron intake with the risk of AMI.
Methods

Subjects
The Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD) is a population study to investigate by guest on June 11, 2016 http://circ.ahajournals.org/ Downloaded from previously unestablished risk factors for AMI and carotid atherosclerosis13 in Eastern Finnish men, the population with the highest recorded incidence of and mortality from CHD.14 This study presents the first prospective analysis based on all participants in the KIHD baseline examinations. These were carried out between March 1984 and December 1989. The study sample included 3, 235 Eastern Finnish men aged 42, 48, 54, or 60 years at the baseline examination. Of these, 2, 682 (82.9%) participated. Men with prevalent CHD (n=677) were excluded from the present analyses. Prevalent ischemic heart disease was defined as either a history of myocardial infarction or angina pectoris, positive angina pectoris on effort in the London School of Hygiene interview,15 or the use of nitroglycerin tablets once a week or more frequently. Of the remaining 2,005 men, data on both serum ferritin and blood hemoglobin concentrations were available for 1,931 men. Data on serum LDL cholesterol, serum high density lipoprotein (HDL) cholesterol, and maximal oxygen uptake were missing for 17, seven, and 191 men, respectively. For these men, the mean value of the variable in question was used; when the variable was dichotomized, they were placed in the category indicating low risk.
Laboratory Methods
The examination protocol and measurements have The method is based on a double antibody technique. The between-batch variation in serum ferritin was determined at three levels of Lyphochek control serum (Bio-Rad, Anaheim, Calif.). The between-batch coefficient of variation was 6.4%, 6.0%, and 10.9% for ferritin levels of 52, 172, and 490 ,ug/l, respectively (n=20).
Blood hemoglobin was measured photometrically (Gilford Stasar III, Instrument Laboratories Inc.) using the cyanmethemoglobin method18 within a few hours of blood sampling. The hemoglobin measurement was calibrated against cyanmethemoglobin standard (Finnish Red Cross, Helsinki). The day-to-day variation of hemoglobin measurement was assessed using commercially available control blood (Merz & Dade AG, Duedingen, Switzerland and 4C, Coulter Diagnostics, Hialeah, Fla.). The between-batch coefficent of variation was 1.2% at the hemoglobin level of 138 g/l and 1.7% at 123 g/l (n = 14). The between-batch coefficient of variation for blood hematocrit was 2.4% for Merz & Dade control, 3.5% for 4C normal control, and 4.0% for 4C abnormal control. Blood cells were counted using the Coulter-Counter cell counter model DN (Coulter Counter Electronics Ltd., Luton, UK).
Plasma ferritin and blood hemoglobin concentrations were redetermined in a subsample of 447 hypercholesterolemic men in samples drawn 1-5 years after the KIHD baseline examination. The Pearson's correlation between the baseline and the remeasurement values was 0.67 for ferritin and 0.71 for hemoglobin.
Copper concentrations were determined from frozen serum specimens (-20°C) 1-5 years after the baseline examination.9 The Perkin-Elmer (Norwalk, Conn.) 306 Atomic Absorption Spectrometer was used with flame atomization against standards made in 5% glycerol. The Seronorm control serum (Nyegaard, Oslo, Norway) was included in all daily batches. The between-batch coefficient of variation was 4.0% (n = 12).
The The number of cigarettes, cigars, and pipefuls of tobacco currently smoked daily, the duration of regular smoking in years, history of myocardial infarction, angina pectoris and other ischemic heart disease, the presence of hypertension, and current antihypertensive medication were recorded using a self-administered questionnaire, which was checked by an interviewer. Reinterviews to obtain medical history were conducted by a physician. The family history of CHD was defined as positive if the biological father, mother, sister, or brother of the subject had CHD history. The history of hypertension in siblings was defined as positive if any sisters or brothers were reported to ever have had hypertension.
A subject was defined as a smoker if he had ever smoked on a regular basis and had smoked cigarettes, cigars, or a pipe within the past 30 days. The lifelong exposure to smoking ("cigarette pack-years") was estimated as the product of years smoked and the number of tobacco products smoked daily at the time of examination. "Years smoked" were defined as the sum of years of smoking regardless of when smoking had started, whether the subject had stopped smoking, or whether it had occurred continuously or during several periods. The consumption of alcohol in the previous 12 months was assessed with the Nordic Alcohol Consumption Inventory, which contains 15 items. 21 Resting blood pressure was measured between 8:00 and 10:00 AM on the first examination day by one nurse with a random-zero mercury sphygmomanometer. The measuring protocol included, after a supine rest of 5 minutes, three measurements in supine, one in standing, and two in sitting position with 5-minutes intervals. The mean of all six systolic pressure values was used in the present analyses as the systolic blood pressure and the mean of all six diastolic measurements as diastolic blood pressure.
The respiratory gas exchange was measured breathby-breath with our study cohort or in the AMI registry data. Therefore, the losses to follow-up were negligible, if any. Between March 1984 and December 1989, a suspected fatal (n =9) or nonfatal (n =42) AMI was registered in 51 of the 1,931 men at risk. Five of these men were hospitalized due to prolonged chest pain, but during the hospitalization, the criteria (ECG and enzymes) for either definite or possible FINMONICA23 AMI were not fulfilled. The statistical analysis was carried out in two ways: by using all 51 registered events and by using only the 46 events that were classified as either a definite or a possible AMI according to the FINMONICA algorithm.23 These analyses gave very similar results, and for that reason only those from the former are presented here. In the case of multiple events during follow-up, the first one for each subject was taken as the end point for the present analyses. There were 28 deaths from causes other than CHD. The follow-up period for individual subjects was up to 53/4 years, and mean follow-up time was approximately 3 years.
Statistical Methods
Associations between blood hemoglobin and serum ferritin concentrations and risk factors for ischemic heart disease were estimated with the Pearson's correlation coefficients adjusted simultaneously for age and the year of the baseline examination (1985 The association of serum ferritin and blood hemoglobin concentrations with serum C-reactive protein and ceruloplasmin concentration was studied in a subsample of 88 men. None of these correlations was statistically significant.
The strongest predictors of AMI, when adjusting only for age (in years) and examination year (covariates for individual years), were pack-years smoked, serum ferritin concentration, maximal oxygen uptake (inversely), serum HDL2 cholesterol concentration, ischemic ECG in exercise, blood hemoglobin, blood leukocyte count, systolic blood pressure, serum copper concentration, diabetes, blood glucose, serum apolipoprotein B and triglyceride concentrations, and diastolic blood pressure ( (Figure 3) . The excess risks of AMI at serum ferritin levels 200-399 ,g/l and .400 ,ug/l were statistically significant and almost identical. As indicated by the 73% reduction in the range of ferritin means between the lowest and the highest ferritin category from the baseline to the reexamination 1-5 years later, there was a strong regression toward the mean in serum ferritin concentration over time. On the basis of this Cox model, an increment of 170 ,tg/l in the baseline (and that of 82 ,.g/l in the usual) serum ferritin concentration was associated with a 2.4-fold age-adjusted and 2.3-fold risk factor-adjusted risk of AMI. An increment of 1% in serum ferritin concentration was associated with an =2.4% increment (4.4% when corrected for the regression dilution bias) in the risk factor-adjusted risk of AMI.
To remove the possible effect of the acute phase of the disease on serum ferritin concentration, the Cox models were repeated, taking into account only myocardial infarctions that occurred more than 6 months after the baseline examination. The strength of the relations between serum ferritin concentration with the risk of AMI remained similar to that based on the entire follow-up period: The age and examination yearadjusted relative hazard for serum ferritin >200 ,ug/l was 2.0 (95% CI, 1.1-3.6; z=2.27, p<0.05). Discussion Extensive reviews have been recently published concerning the role of iron in free radical reactions, such as lipid peroxidation.3-6 Briefly, except in states of iron overload, all iron in human serum is bound to proteins. About two thirds of body iron is found in hemoglobin, with smaller amounts in myoglobin, various enzymes, and the transport protein transferrin. 6 Iron not required for these is largely stored in ferritin. To promote free radical production, iron must be liberated from proteins. It is believed that oxidant stress itself can provide the iron necessary for formation of reactive oxygen species, for example, by mobilizing iron from ferritin or by degrading heme proteins to release iron.6 For instance, superoxide radicals have been observed to liberate iron from ferritin, promoting lipid peroxidation.626 Halliwell and Gutteridge6 have proposed that the general effect of iron catalysts is to convert poorly reactive free radicals into highly reactive ones, such as the hydroxyl radical.
Recently, Balla and coworkers27 demonstrated that the combination of physiological concentrations of hydrogen peroxide and hemin induce a rapid peroxidation of LDL in vitro and that free iron is released from the degraded heme ring. They also observed a simultaneous loss of reactive lysine amino groups of LDL, which has been shown to promote LDL uptake by scavenger receptors of macrophages leading to foam cell formation.' Also, transition metal ions are probably required for the peroxidation of LDL by monocyte/macrophages, smooth muscle cells, and endothelial cells.2829 Oxyhemoglobin has been observed to stimulate lipid peroxidation.30 Also, iron released from ferritin has been shown to stimulate the formation of hydroxyl radicals from superoxide radicals and hydrogen peroxide,3' whereas apoferritin appears to inhibit lipid peroxidation. 32 In patients with iron overload consequent of hereditary hemochromatosis, nontransferrin-bound iron, reflecting free iron, is present in serum, and its concentration is highly correlated to that of serum ferritin, even at serum ferritin levels <400 gg/1.33 Thus, the hypothesis that high iron status is associated with stimulated free radical reactions and accelerated lipid peroxidation in the human body appears to be plausible on the basis of free radical chemistry and animal experiments.
Iron loading has been observed to increase the susceptibility of rat hearts to oxygen reperfusion damage.6 '34 There are a number of animal experiments suggesting that experimental ischemic myocardial injury can be limited or prevented by iron chelation therapy.?8, 34 The chelation of iron has been found to prevent postischemic lipid peroxidation in rats. 34 Recently, Williams et al8 found that desferrioxamine treatment improved the functional and metabolic recovery of isolated, perfused rabbit hearts after 30 minutes of ischemia. Korpela3s observed increased hepatic and myocardial iron concentrations in pigs with microangiopathy (mulberry heart disease) compared with healthy pigs. Smith and coworkers36 recently demonstrated catalytic iron in gruel samples from human advanced atherosclerotic lesions. The samples stimulated lipid peroxidation, and this was in most samples inhibited by the iron chelator desferrioxamine.
Murray and coworkers37 measured the inhibitory effect on lipid auto-oxidation of the serum of milkdrinking nomads, who have nutritional iron and copper deficiency.37 Twenty-two nomads were given 180 mg of iron daily for 60 days without change in diet. Besides by promoting lipid peroxidation, high iron status could increase the risk of AMI through the elevation of blood hematocrit and blood hemoglobin concentration. This increases the viscosity of blood, which could be related to thrombotic coronary events through a direct thrombogenic effect. In our study population, however, the association of serum ferritin both with blood hemoglobin (r=0.21) and with hematocrit (r=0.16) was quite weak. Also, there was a relation between serum ferritin concentration and the risk of hematocrit and hemoglobin, whereas blood hematocrit and hemoglobin had no significant association with AMI risk when serum ferritin was allowed for. The association between serum ferritin and AMI risk was weakened by only 12% by the adjustment for hematocrit and hemoglobin. This suggests that the AMI risk-elevating effect of high serum ferritin is primarily through mechanisms other than increased blood viscosity.
Apoferritin is a liver protein that is elevated in inflammatory conditions, even though not as much as the actual acute-phase proteins. To rule out the possibility that serum ferritin levels merely reflect the presence of an infection, inflammation, or chronic vascular disease, we adjusted for the blood leukocyte count in our statistical analysis. Serum ferritin had no association either with the concentration of plasma fibrinogen (an acute-phase protein) in the whole study population or with serum C-reactive protein or serum ceruloplasmin concentrations in a subsample. The impact of high serum ferritin on the risk of AMI did not attenuate when infarctions that occurred within 6 months of blood sampling were excluded from the statistical analysis.
Iron status was associated in our data with several risk factors for CHD. Serum ferritin had significant correlations (in order of strength) with blood glucose, serum triglycerides, systolic blood pressure, HDL2 cholesterol concentration (inversely), and serum apolipoprotein B concentration. As serum ferritin had weak positive correlations with the intakes of alcohol, meat, and saturated fats, these associations may be partly of dietary origin. Serum ferritin also correlated inversely with maximal oxygen uptake, an indicator of cardiorespiratory fitness. This is a suprising finding, as high hemoglobin concentration enhances the transport of oxygen from the lungs to the muscles. There are two possible explanations for this observation: Most likely, high physical activity might increase iron excretion, as suggested earlier49; theoretically, high iron status could also lower cardiorespiratory performance capacity through a direct effect on the cardiac muscle.
We found no reports concerning the effects of iron depletion by chelation therapy 
